About Zymes Bioscience Private Limited
Data last updated:
Zymes Bioscience Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 April 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51102DL2012PTC234105. Its GSTIN is 07AAACZ5888J2ZL (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shivali Choudhary and Chandan Chopra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No. 1 2nd Floor B – 20 Okhla Industrial Area Ph – 2, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹49.64 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹1.62 Cr (net margin 3.3%) and EBITDA of ₹2.44 Cr (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 84% over five years.
The company has about 51 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Zymes Bioscience. Court records list 5 cases involving the company, including 5 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zymesbioscience.net.
Company details
Contact details
Zymes Bioscience Private Limited's registered office is in New Delhi, Delhi. Its website is zymesbioscience.net. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressOffice No. 1 2nd Floor B – 20 Okhla Industrial Area Ph – 2, New Delhi, Delhi, India – 110020
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Zymes Bioscience Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Zymes Bioscience operates one associated brand: Zymes Bioscience. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops innovative antibiotic therapies for medical treatment and bacterial resistance. | zymesbioscience.net |
Business activity
The main business activity of Zymes Bioscience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Zymes Bioscience Private Limited, buy the company report.
Financials of Zymes Bioscience Private Limited
FY 2025 filings availableZymes Bioscience Private Limited reported revenue of ₹49.64 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 84% over five years, including 23% growth in the latest year. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹49.64 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.44 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.62 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | ||||
| Net Profit Margin | 3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zymes Bioscience Private Limited, buy the company report.
Board of directors of Zymes Bioscience Private Limited
Zymes Bioscience has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivali Choudhary Also directs: Zalix Pharmaceuticals Private Limited | Director | 25 May 2022 | 4 Years 5 Months | Current |
| Chandan Chopra | Director | 01 May 2024 | 2 Years 6 Months | Current |
Auditor
Zymes Bioscience Private Limited is audited by JAIBHAGWANSHARMA for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAIBHAGWANSHARMA | FY 2022 | 082540 |
Shareholding
The shareholding of Zymes Bioscience Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Zymes Bioscience Private Limited, buy the company report.
Legal cases
Zymes Bioscience Private Limited has 5 court cases on record: 5 filed against it. 1 case is pending and 4 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 3 | 0 |
| District courts | 2 | 2 | 1 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Aristo Pharmaceuticals Private Limited | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Aristo Pharmaceuticals Private Limited | Disposed |
| District court, South East, Delhi | Civil suit | Filed against the company by an individual | Pending |
| High Court of Delhi | Commercial suit | Filed against the company by Wockhardt Limited | Disposed |
| District court, Medchal Malkajgiri, Telangana | Criminal complaint | Filed against the company by an individual | Disposed |
To see the full case history of Zymes Bioscience Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zymes Bioscience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Zymes Bioscience Private Limited has a workforce of 51 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
GST
Zymes Bioscience has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACZ5888J2ZL | Delhi | Active | 18 Apr 2019 |
To see the full GST registrations and return filing status of Zymes Bioscience Private Limited, buy the company report.
Recent activity
Zymes Bioscience Private Limited has 8 board changes on record since 2017: 2 appointments and 6 cessations. The latest: Binny Chopra ceased to be Director on 02 May 2024.
Frequently asked questions
Zymes Bioscience is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 April 2012 (14+ years old) and is registered under CIN U51102DL2012PTC234105.
Zymes Bioscience has 2 current directors:
- Shivali Choudhary - Director
- Chandan Chopra - Director
The latest financial statements of Zymes Bioscience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Zymes Bioscience is 07AAACZ5888J2ZL, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Zymes Bioscience is U51102DL2012PTC234105. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zymes Bioscience has 5 court cases on record: 5 filed against it. 1 is pending. Most are in the high courts.
Zymes Bioscience was incorporated on 09 April 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
Binny Chopra ceased to be Director on 02 May 2024. Chandan Chopra was appointed as Director on 01 May 2024. Suchinder Kaur ceased to be Director on 26 May 2022. Zymes Bioscience has 8 board changes on record in total.
Zymes Bioscience can be reached through the website zymesbioscience.net. Its registered office is in New Delhi, Delhi, India.
The registered office of Zymes Bioscience is at Office No. 1 2nd Floor B – 20 Okhla Industrial Area Ph – 2, New Delhi, Delhi, India – 110020.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
